Lyon Street Capital, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
Lyon Street Capital, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$1,237,000
-51.4%
9,113
-1.7%
1.24%
-21.5%
Q3 2018$2,545,000
-61.6%
9,272
-71.0%
1.58%
-32.8%
Q2 2018$6,627,000
-2.5%
31,988
-22.2%
2.36%
+7.7%
Q1 2018$6,794,000
+24.8%
41,133
+3.5%
2.19%
+20.6%
Q4 2017$5,444,00039,7561.82%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders